S. 3788

Status: Reported

CLEAR LABELS Act

CLEAR LABELS Act

Sponsored by Rick Scott (Republican-FL)

Topics

Cosponsors

12

Actions

7

Roll calls

0

Amendments

0

Related bills

1

Actions

Jul 27, 2026 · Library of Congress

Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.

Jul 27, 2026 · Senate

Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.

Jul 27, 2026 · Senate

Placed on Senate Legislative Calendar under General Orders. Calendar No. 523.

Jul 22, 2026 · Senate

Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.

Mar 19, 2026 · Senate

Committee on Health, Education, Labor, and Pensions. Hearings held.

Feb 5, 2026 · Library of Congress

Introduced in Senate

Feb 5, 2026 · Senate

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Latest activity

July 2026

Bill reported · Jul 27Reported

CLEAR LABELS Act

Bill reported · Jul 27Reported

CLEAR LABELS Act

Bill reported · Jul 22Reported

CLEAR LABELS Act

Lobbying reported · Biotechnology Innovation Organization · Jul 21

Biotechnology Innovation Organization reported 2nd Quarter (Apr 1 - June 30) lobbying for Biotechnology Innovation Organization — $2,360,000

Lobbying reported · Association for Accessible Medicines · Jul 20

Association for Accessible Medicines reported 2nd Quarter (Apr 1 - June 30) lobbying for Association for Accessible Medicines — $870,000

BillsH.R. 3160 H.R. 3269 H.R. 5526 H.R. 5811 H.R. 6485 H.R. 7148 H.R. 8269 H.R. 8339 S. 43 S. 1041 S. 1096 S. 1414 S. 1546 S. 1553 S. 1954 S. 2658 S. 3469 S. 3788

Lobbying reported · Bayer · Jul 20

Bayer reported 2nd Quarter (Apr 1 - June 30) lobbying for Bayer — $1,820,000

BillsH.R. 1492 H.R. 1897 H.R. 3160 H.R. 3269 H.R. 7366 H.R. 7567 H.R. 9171 H.R. 9260 S. 832 S. 1546 S. 1553 S. 3122 S. 3677 S. 3788

Lobbying reported · The Nickles Group · Jul 20

The Nickles Group reported 2nd Quarter (Apr 1 - June 30) lobbying for Amgen — $60,000

BillsH.R. 1 S. 1954 S. 2658 S. 3014 S. 3788

Lobbying reported · The United States Pharmacopeial Convention · Jul 20

The United States Pharmacopeial Convention reported 1st Quarter (Jan 1 - Mar 31) lobbying for The United States Pharmacopeial Convention — $130,000

BillsH.R. 4191 S. 1784 S. 3788

Lobbying reported · The United States Pharmacopeial Convention · Jul 20

The United States Pharmacopeial Convention reported 2nd Quarter (Apr 1 - June 30) lobbying for The United States Pharmacopeial Convention — $120,000

BillsH.R. 4191 H.R. 4779 H.R. 5304 H.R. 8800 S. 1784 S. 2296 S. 2587 S. 3788

Lobbying reported · American Hospital Association · Jul 20

American Hospital Association reported 2nd Quarter (Apr 1 - June 30) lobbying for American Hospital Association — $4,470,000

Lobbying reported · Amgen · Jul 20

Amgen reported 2nd Quarter (Apr 1 - June 30) lobbying for Amgen — $2,440,000

Lobbying reported · Pharmaceutical Research and Manufacturers of America (PhRMA) · Jul 20

Pharmaceutical Research and Manufacturers of America (PhRMA) reported 2nd Quarter (Apr 1 - June 30) lobbying for Pharmaceutical Research and Manufacturers of America (PhRMA) — $7,360,000

Lobbying reported · National Association of Chain Drug Stores (NACDS) · Jul 20

National Association of Chain Drug Stores (NACDS) reported 2nd Quarter (Apr 1 - June 30) lobbying for National Association of Chain Drug Stores (NACDS) — $290,000

BillsH.R. 2484 H.R. 2853 H.R. 3164 H.R. 4317 H.R. 4581 H.R. 6400 H.R. 6501 H.R. 6575 H.R. 6609 H.R. 8779 H.R. 8800 S. 526 S. 527 S. 882 S. 927 S. 1404 S. 2426 S. 2626 S. 3345 S. 3788 S. 3822 S. 4106 S. 4509 S. 4784

Lobbying reported · Professional Compounding Centers Of America · Jul 20

Professional Compounding Centers Of America reported 2nd Quarter (Apr 1 - June 30) lobbying for Professional Compounding Centers Of America — $220,000

BillsH.R. 5316 H.R. 6509 H.R. 8269 S. 3788 S. 3794

Lobbying reported · Novartis · Jul 20

Novartis reported 2nd Quarter (Apr 1 - June 30) lobbying for Novartis — $1,410,000

Lobbying reported · Fierce Government Relations · Jul 20

Fierce Government Relations reported 2nd Quarter (Apr 1 - June 30) lobbying for Association Of Accessible Medicines — $60,000

BillsH.R. 7410 S. 1414 S. 1954 S. 2658 S. 3014 S. 3788 S. 4327 S. 4784

Lobbying reported · National Community Pharmacists Association · Jul 17

National Community Pharmacists Association reported 2nd Quarter (Apr 1 - June 30) lobbying for National Community Pharmacists Association — $270,000

Lobbying reported · Van Scoyoc Associates · Jul 17

Van Scoyoc Associates reported 2nd Quarter (Apr 1 - June 30) lobbying for National Association of Chain Drug Stores (NACDS) — $80,000

BillsH.R. 3164 S. 882 S. 3788

Lobbying reported · Glaxosmithkline · Jul 16

Glaxosmithkline reported 2nd Quarter (Apr 1 - June 30) lobbying for Glaxosmithkline — $890,000

Lobbying reported · Consumer Healthcare Products Association (CHPA) · Jul 14

Consumer Healthcare Products Association (CHPA) reported 2nd Quarter (Apr 1 - June 30) lobbying for Consumer Healthcare Products Association (CHPA) — $199,750

BillsH.R. 1 H.R. 1219 H.R. 2821 H.R. 3686 H.R. 3722 H.R. 4273 H.R. 4958 H.R. 5027 H.R. 5371 H.R. 6868 H.R. 7291 H.R. 7366 H.R. 8370 H.R. 8385 H.R. 8933 S. 355 S. 2292 S. 2529 S. 3122 S. 3788 S. 4587